Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

Science Watch logo

JID Article Named "New Hot Paper" by ScienceWatch.com

Dr. Lauri Hicks' 2007 article on pneumococcal disease has been named a "hot new paper" by Thompson Reuters' ScienceWatch.com. Read a Q&A about the article with Dr. Hicks here

Press Release

Unique Collaboration Charts the Migrations of a Parasite that Affected History
Researchers Sequence Louse DNA from Mummies and Propose New Model for its Development


In the News

Featured in Grist
"Another symptom of swine flu: instant amnesia" May 11, 2009
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Read the veterinary literature on swine flu and you get a strong sense of what might be called vaccination treadmill: the hog industry is literally scrambling to generate new vaccines for the rapidly evolving flu strains that sweep through CAFOs. Writing in the Journal of Infectious Diseases [PDF] in 2008, Eileen Thacker and Bruce Janke of Iowa State University paint a stark picture: “A number of genetically diverse viruses are circulating in swine herds throughout the world and are a major cause of concern to the swine industry,” they write. “Influenza virus infections in swine and poultry are potential sources of viruses for the next pandemic among humans.”

Featured in New York Times
"Fear of a Swine Flu Epidemic in 1976 Offers Some Lessons, and Concerns, Today" May 8, 2009
Anti‐Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine‐Associated Guillain‐Barré Syndrome
Irving Nachamkin, Sean V. Shadomy, Anthony P. Moran, Nancy Cox, Collette Fitzgerald, Huong Ung, Adrian T. Corcoran, John K. Iskander, Lawrence B. Schonberger, and Robert T. Chen
Irving Nachamkin, a professor of pathology and laboratory medicine at the University of Pennsylvania, examined some 1976 vaccine that had been saved by a scientist in Texas. In a paper published last year in The Journal of Infectious Diseases, he and colleagues reported that mice given the vaccine made antibodies that reacted with gangliosides, which are components of nerve cells. An antibody attack on gangliosides is part of the disease mechanism of Guillain-Barré.

Featured in AFP
"Swine flu vaccine 'could be ready soon'" May 7, 2009
A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza Viruses
Mary A. Hoelscher, Neetu Singh, Sanjay Garg, Lakshmi Jayashankar, Vic Veguilla, Aseem Pandey, Yumi Matsuoka, Jacqueline M. Katz, Ruben Donis, Suresh K. Mittal, and Suryaprakash Sambhara
The vaccine Mittal created for the bird flu worked on three different strains isolated over a seven-year period and was described in papers for the Journal of Infectious Diseases and the journal Clinical Pharmacology and Therapeutics.

Featured in Newsweek
"The Path of a Pandemic" http://www.newsweek.com/id/195692
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Last year researchers from Iowa State University in Ames warned that pigs located in industrial-scale farms were being subjected to influenza infections from farm poultry, wild birds and their human handlers. Writing in The Journal of Infectious Diseases, Eileen Thacker and Bruce Janke said, "As a result of the constantly changing genetic makeup of individual influenza viruses in pigs, the U.S. swine industry is continually scrambling to respond to the influenza viruses circulating within individual production systems."

15 April 2007

Volume 195, Number 8
The Journal of Infectious Diseases 2007;195:1089–1096
0022-1899/2007/19508-0004$15.00
DOI: 10.1086/512680
MAJOR ARTICLE

Severe Dengue Virus Infection in Travelers: Risk Factors and Laboratory Indicators

Ole Wichmann,1,3

Joaquim Gascon,7

Mirjam Schunk,4

Sabino Puente,8

Heli Siikamaki,11

Ida Gjørup,12

Rogelio Lopez‐Velez,9

Joannes Clerinx,13

Gabriele Peyerl‐Hoffmann,5

Anders Sundøy,14

Blaise Genton,15

Peter Kern,6

Guido Calleri,16

Miguel de Górgolas,10

Nikolai Mühlberger,2 and

Tomas Jelinek,2 for the

European Network on Surveillance of Imported Infectious Diseases

1Institute of Tropical Medicine, Charité University Medicine, 2Berlin Center for Travel and Tropical Medicine, and 3Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin; 4Department of Infectious Diseases and Tropical Medicine, University of Munich, Munich, 5Infectious Disease Clinic, Abteilung Innere Medizin II, University of Freiburg, Freiburg, and 6Sektion Infektiologie und Klinische Immunologie, University of Ulm, Ulm, Germany; 7Centre Salut Internacional, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clinic Barcelona, and 8Department of Infectious Diseases and Tropical Medicine, Hospital Carlos III, 9Tropical Medicine and Clinical Parasitology Unit, Infectious Diseases–Microbiology Department, Hospital Ramon y Cajal, and 10Fundación Jiménez Díaz, Division of Infectious Disease, Madrid, Spain; 11Helsinki University Central Hospital, Department of Medicine, Division of Infectious Diseases, Helsinki, Finland; 12Rigshospitalet Copenhagen, University of Copenhagen, Denmark; 13Prins Leopold Instituut voor Tropische Geneskunde, Clinical Services, Antwerp, Belgium; 14Sorlandet Hospital, Kristiansand, Norway; 15Travel Clinic at the Policlinique Médicale Universitaire, University of Lausanne, Lausanne, Switzerland; 16Division “A” Malattie Infettive, Ospedale Amedeo di Savoia, Torino, Italy

Background.Dengue fever is the most common arboviral disease in travelers. In countries where dengue virus is endemic, sequential (secondary) infections with different dengue virus serotypes are associated with disease severity. Data on severity and secondary infection rates in a population of travelers are lacking.

Methods.Intensified surveillance of dengue fever in travelers was performed within the European Network on Surveillance of Imported Infectious Diseases. Data were collected at 14 European clinical referral centers between 2003 and 2005.

Results.A total of 219 dengue virus infections imported from various regions of endemicity were reported. Serological analysis revealed a secondary immune response in 17%. Spontaneous bleeding was observed in 17 (8%) patients and was associated with increased serum alanine and aspartate aminotransferase levels and lower median platelet counts. Two (0.9%) patients fulfilled the World Health Organization (WHO) case definition for dengue hemorrhagic fever. However, 23 (11%) travelers had severe clinical manifestations (internal hemorrhage, plasma leakage, shock, or marked thrombocytopenia). A secondary immune response was significantly associated with both spontaneous bleeding and other severe clinical manifestations.

Conclusions.In travelers, severe dengue virus infections are not uncommon but may be missed if the WHO classification is strictly applied. High liver enzyme levels and low platelet counts could serve as indicators of disease severity.

Received 30 June 2006; accepted 26 September 2006; electronically published 2 March 2007.

Reprints or correspondence: Dr. Ole Wichmann, Robert Koch Institute, Dept. for Infectious Disease Epidemiology, Seestr. 10, 13353 Berlin, Germany ().

Cited by

Annelies Wilder-Smith, Jacqueline L Deen. (2008) Dengue vaccines for travelers. Expert Review of Vaccines 7:5, 569-578
Online publication date: 1-Aug-2008.
CrossRef
Adriana O. Guilarde, Marilia D. Turchi, Joao Bosco Siqueira Jr., Valeria C. R. Feres, Benigno Rocha, Jose E. Levi, Vanda A. U. F. Souza, Lucy Santos Vilas Boas, Claudio S. Pannuti, and Celina M. T. Martelli. (2008) Dengue and Dengue Hemorrhagic Fever among Adults: Clinical Outcomes Related to Viremia, Serotypes, and Antibody Response. The Journal of Infectious Diseases 197:6, 817-824
Online publication date: 15-Mar-2008.
Annelies Wilder-Smith and Paul Ananth Tambyah. (2007) Severe Dengue Virus Infection in Travelers. The Journal of Infectious Diseases 195:8, 1081-1083
Online publication date: 15-Apr-2007.
  • Potential conflicts of interest: none reported.

    Presented in part: 9th Conference of the International Society of Travel Medicine, Lisbon, 1–5 May 2005 (poster 06.22).

    Financial support: Society for Tropical and Travel Medicine.

Close Popup